Pages that link to "Q36169413"
The following pages link to Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin (Q36169413):
Displaying 3 items.
- Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes (Q37204124) (← links)
- Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter (Q64331279) (← links)
- Antidiabetic Potential of Marine Brown Algae-a Mini Review (Q94596365) (← links)